HLA-A, -B, -C genotyping and expression in human nonlymphoid tumor cell lines

Journal of Immunotherapy

Volumn 22, Issue 1, 1999, Pages 7-15

  Delfino, Laura ^a   Ciccarelli, Gina ^b   Bini, Davide ^a   Morabito, Anna ^a   Pozzi, Sarah ^a   Martayan, Aline ^b   Giorda, Ezio ^b   Setini, Andrea ^b   Fraioli, Rocco ^b   Giacomini, Patrizio ^b   Ferrara, Giovan Battista ^a  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

HLA typing; HLA A; HLA B; HLA C; IEF; PCR

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BLADDER CARCINOMA; COLON CARCINOMA; GENOTYPE; HLA TYPING; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; KIDNEY CARCINOMA; MELANOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; TUMOR CELL LINE;

ALLELES; ANTIBODIES, MONOCLONAL; CELL MEMBRANE; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; ISOELECTRIC FOCUSING; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0032953844     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199901000-00002     Document Type: Article

References (37)

1. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
2. Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997; 18:175-82.
3. Mittal KK, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation. XVIII. Refinement of microdroplet cytotoxicity test. Transplantation 1968;6:913-27.
4. Takasugi M, Terasaki PI. Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test. J Natl Cancer Inst 1972;49:1229-37.
5. Pellegrino MA, Ferrone S, Reisfeld RA, Irie RF, Golub SH. Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma. Cancer 1977;40:36-41.
6. Espmark JA, Ahlqvist-Roth L, Sarne L, Persson A. Tissue typing of cells in culture III. HLA antigens of established human cell lines: attemps at typing by the mixed hemadsorption technique. Tissue Antigens 1978;11:279-86.
7. Saxton RE, Irie RF, Ferrone S, Pellegrino MA, Morton DL. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Int J Cancer 1978;21:299-306.
8. Pollack MS, Heagney SD, Livingston PO, Fogh J. HLA-A,B,C and DR alloantigen expression on forty-six cultured human tumor cell lines. J Natl Cancer Inst 1981;66:1003-11.
9. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993;14:491-9.
10. Neefjes JJ, Breur-Vriesendorp BS, Seventer I, Ivanyi P, Ploegh HL. Improved biochemical method for the analysis of HLA-class I antigens: definition of new HLA-class I subtypes. Immunology 1986;16:169-81.
11. Kimura A, Hoshino S, Yoshida M, Harada H, Sasazuki T. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of HLA genes: a practical HLA-matching system. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Oxford: Oxford University Press, 1992:511-4.
12. Sadler AM, Petronzelli F, Krausa P, et al. Low-resolution DNA typing for HLA-B using sequence-specific primers in allele-or group-specific ARMS/PCR. Tissue Antigens 1994;44:148-54.
13. Bugawan TL, Apple R, Erlich HA. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. Tissue Antigens 1994;44:137-47.
14. Petersdorf EW, Hansen JA. A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing. Tissue Antigens 1995;46:73-85.
15. Ruiz-Cabello F, Perez-Ayala M, Gomez O, et al. Molecular analysis of MHC-class-I alterations in human tumor cell lines. Int J Cancer 1991;49(suppl 6):123-30.
16. Wang P, Vànky F, Li S-L, Végh ZS, Persson U, Klein E. Expression of MHC-class-I antigens in human carcinomas and sarcomas analyzed by isoelectric focusing. Int J Cancer 1991;6:106-16.
17. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993;90:2842-5.
18. Adams SD, Marincola FM, Shamamian P, Simonis TB, Davey RJ. HLA class I typing of tumor cell lines using fluorescence activated cell sorting (FACS) and complement mediated cytotoxicity (CDC) [Abstract]. Hum Immunol 1993;37:149.
19. Pera C, Delfino L, Morabito A, et al. HLA-A typing: comparison among serology, ARMS-PCR and sequencing. Tissue Antigens 1997;50:372-9.
20. Fogh J, Trempe G. New human tumor cell lines. In: Fogh J, ed. Human tumor cells in vitro. New York and London: Plenum, 1975: 115-59.
21. Giacomini P, Tecce R, Gambari R, Sacchi A, Fisher PB, Natali PG. Recombinant human IFN-γ, but not IFN-α or IFN-β, enhances MHC-and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism. J Immunol 1988;140:3073-81.
22. 2m gene. J Clin Invest 1991;88:282-9.
23. 2-microglobulin gene-null FO-1 melanoma cells. Cancer Res 1993;53:4303-9.
24. 2m gene expression. J Clin Invest 1992;87: 284-92.
25. Barletta C, Bartolazzi A, Cimino Reale G, et al. Cytogenetic, molecular and phenotypic characterization of the newly established renal carcinoma cell line KJ29: evidence of translocations for chromosomes 1 and 3. Anticancer Res 1995;15:2129-36.
26. 2-microglobulin. Hum Immunol 1997;53:23-33.
27. Setini A, Beretta A, De Santis C, et al. Distinctive features of the α1 domain α helix of HLA-C heavy chains free of β2-microglobulin. Hum Immunol 1996;46:69-81.
28. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serologically and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994;43:7-17.
29. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979;47:3-61.
30. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 1995;181:2085-95.
31. 2m associated heavy chains of HLA-A, -B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28. Immunogenetics 1981;13:285-95.
32. Benjamin RJ, Abrams JR, Parnes JR, Madrigal JA, Parham P. Polymorphic specificity of Q1/28, a monoclonal antibody that preferentially reacts with free class I heavy chains. Immunogenetics 1992;37:73-6.
33. 2m: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and IFN-γ responsiveness. Tissue Antigens 1997;50:553-66.
34. Ploegh HL, Cannon LE, Strominger JL. Cell-free translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens. Proc Natl Acad Sci USA 1979;76:2273-7.
35. Stevens EJ, Jacknin L, Robbins PF, et al. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines: fine specificity and MART-1 melanoma antigen recognition. J Immunol 1995;154:762-71.
36. Player MA, Barracchini KC, Simonis TB, et al. Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocols. J Immunother 1996;19:357-63.
37. Hajek-Rosenmayr A, Jungl L, Stammler M, Kirnbauer M. HLA-C locus antigens seen by one-dimensional isoelectric focusing: definition of the so far known HLA-C specificities and of two subtypes. Hum Immunol 1989;26:227-36.